[PHARMA] YoY Annualized Quarter Result on 31-Mar-2014 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
14-May-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
31-Mar-2014 [#1]
Profit Trend
QoQ- 89.98%
YoY- 5.84%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 2,473,176 2,236,780 1,887,616 1,874,688 2,001,356 1,786,980 1,541,312 8.19%
PBT 111,108 106,152 154,448 152,636 147,696 171,820 87,168 4.12%
Tax -34,076 -32,272 -26,744 -46,052 -47,084 -55,576 -24,772 5.45%
NP 77,032 73,880 127,704 106,584 100,612 116,244 62,396 3.57%
-
NP to SH 75,692 73,516 127,176 104,868 99,084 114,740 61,936 3.39%
-
Tax Rate 30.67% 30.40% 17.32% 30.17% 31.88% 32.35% 28.42% -
Total Cost 2,396,144 2,162,900 1,759,912 1,768,104 1,900,744 1,670,736 1,478,916 8.36%
-
Net Worth 544,360 515,906 528,173 515,022 484,829 474,161 437,661 3.69%
Dividend
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Div 41,475 41,417 72,494 41,408 35,303 35,297 - -
Div Payout % 54.79% 56.34% 57.00% 39.49% 35.63% 30.76% - -
Equity
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Net Worth 544,360 515,906 528,173 515,022 484,829 474,161 437,661 3.69%
NOSH 259,219 258,859 258,908 258,805 117,676 117,657 107,007 15.87%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin 3.11% 3.30% 6.77% 5.69% 5.03% 6.51% 4.05% -
ROE 13.90% 14.25% 24.08% 20.36% 20.44% 24.20% 14.15% -
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 954.09 864.09 729.07 724.36 1,700.72 1,518.79 1,440.38 -6.62%
EPS 29.20 28.40 49.12 40.52 84.20 97.52 57.88 -10.76%
DPS 16.00 16.00 28.00 16.00 30.00 30.00 0.00 -
NAPS 2.10 1.993 2.04 1.99 4.12 4.03 4.09 -10.50%
Adjusted Per Share Value based on latest NOSH - 258,805
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
RPS 171.60 155.20 130.97 130.07 138.86 123.99 106.94 8.19%
EPS 5.25 5.10 8.82 7.28 6.87 7.96 4.30 3.37%
DPS 2.88 2.87 5.03 2.87 2.45 2.45 0.00 -
NAPS 0.3777 0.358 0.3665 0.3573 0.3364 0.329 0.3037 3.69%
Price Multiplier on Financial Quarter End Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 -
Price 4.89 5.76 6.00 4.46 8.26 5.90 5.73 -
P/RPS 0.51 0.67 0.82 0.62 0.49 0.39 0.40 4.12%
P/EPS 16.75 20.28 12.21 11.01 9.81 6.05 9.90 9.15%
EY 5.97 4.93 8.19 9.09 10.19 16.53 10.10 -8.38%
DY 3.27 2.78 4.67 3.59 3.63 5.08 0.00 -
P/NAPS 2.33 2.89 2.94 2.24 2.00 1.46 1.40 8.85%
Price Multiplier on Announcement Date
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Date 16/05/17 13/05/16 18/05/15 14/05/14 15/05/13 03/05/12 13/05/11 -
Price 4.72 5.60 6.91 4.70 9.26 5.90 5.05 -
P/RPS 0.49 0.65 0.95 0.65 0.54 0.39 0.35 5.76%
P/EPS 16.16 19.72 14.07 11.60 11.00 6.05 8.72 10.81%
EY 6.19 5.07 7.11 8.62 9.09 16.53 11.46 -9.74%
DY 3.39 2.86 4.05 3.40 3.24 5.08 0.00 -
P/NAPS 2.25 2.81 3.39 2.36 2.25 1.46 1.23 10.57%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment